title: Summary of the consultation on a strategy for services for chronic obstructive pulmonary disease (COPD) in England.
abstract: The Consultation on a Strategy for Services for COPD in England is the culmination of five years' work by respiratory specialists from all disciplines, as well as representatives from the voluntary sector, patients, carers and planners. It has been led by the Department of Health in England and the joint National Directors for the programme, Professor Sue Hill and Dr Robert Winter. The Strategy outlines service standards for providers of COPD care and is complementary to the UK National Institute for Health and Clinical Excellence (NICE) guidelines on the management of COPD. Its key elements are: • preventing the development and progression of COPD • diagnosing COPD accurately and at an early stage • developing structured care based on national guidance • promoting self-management education • reducing the number of people admitted to hospital • improving access to end-of-life care • promoting good asthma services. In essence this is an aspirational strategy which aims to change the way that the NHS in England delivers care for people with COPD by identifying them earlier and managing them optimally in order to reduce the likelihood of progression to the more severe stages of the disease. An economic impact assessment shows that implementing the Strategy will save approximately £1billion over 10 years as well as sparing many people from a debilitating illness. This supplement is based on the Strategy Consultation document as well as the NICE guidelines for COPD management. It aims to elucidate practical implementation of the COPD Strategy, and includes verbatim the Strategy recommendations as well as highly relevant clinical information from the NICE guidelines. Implementation of the Strategy recommendations should lead to optimum care for patients with COPD.
authors.affiliation: Peninsula Medical School, University of Plymouth, UK. rupert.jones@pms.ac.uk
authors.forename: Rupert
authors.initials: R
authors.lastname: Jones
authors.forename: Kevin
authors.initials: K
authors.lastname: Gruffydd-Jones
authors.forename: Hilary
authors.initials: H
authors.lastname: Pinnock
authors.forename: Sarah-Jane
authors.initials: SJ
authors.lastname: Peffers
authors.forename: Judith
authors.initials: J
authors.lastname: Lawrence
authors.forename: Jane
authors.initials: J
authors.lastname: Scullion
authors.forename: Patrick
authors.initials: P
authors.lastname: White
authors.forename: Steve
authors.initials: S
authors.lastname: Holmes
mesh_terms: D000465:Algorithms; D001249:Asthma / Q000175:diagnosis; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002908:Chronic Disease; D003937:Diagnosis, Differential; D019468:Disease Management; D004739:England; D015444:Exercise; D019983:Guideline Adherence; D006291:Health Policy; D006801:Humans; D010102:Oxygen Inhalation Therapy; D017410:Practice Guidelines as Topic; D011320:Primary Health Care; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D012138:Respiratory Therapy; D012307:Risk Factors; D012648:Self Care; D012720:Severity of Illness Index; D016540:Smoking Cessation; D013147:Spirometry; D013315:Stress, Psychological / Q000517:prevention & control; D013727:Terminal Care
chemical_list: D001993:Bronchodilator Agents